SYUZANNA MARKOSYAN: Open Payments
NPI 1245075126 · SUNLAND, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$545 in 21 payments from 13 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $545
Food & beverage: $347Education: $198
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 8 | $146 |
| Ipsen Biopharmaceuticals, Inc | 2 | $124 |
| Iovance Biotherapeutics, Inc. | 1 | $33 |
| PharmaEssentia USA Corporation | 1 | $33 |
| Merck Sharp & Dohme LLC | 1 | $29 |
| Lilly USA, LLC | 1 | $27 |
| Celgene Corporation | 1 | $25 |
| Janssen Biotech, Inc. | 1 | $25 |
| EMD Serono, Inc. | 1 | $24 |
| E.R. Squibb & Sons, L.L.C. | 1 | $24 |
Products named: Enhertu, Amtagvi, BESREMI, LYNPARZA, VERZENIO, Onivyde, REBLOZYL, CARVYKTI.
Industry payments across CA — which companies pay providers there.
